Home > Research > Publications & Outputs > Low dose, early mucosal exposure will minimize ...

Research

Associated organisational unit

Links

Text available via DOI:

View graph of relations

Low dose, early mucosal exposure will minimize the risk of microbial disease

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Low dose, early mucosal exposure will minimize the risk of microbial disease. / Morris, James A; Harrison, Linda M; Lauder, Robert M et al.
In: Medical Hypotheses, Vol. 79, No. 5, 11.2012, p. 630-634.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Morris, JA, Harrison, LM, Lauder, RM, Telford, DR & Neary, R 2012, 'Low dose, early mucosal exposure will minimize the risk of microbial disease', Medical Hypotheses, vol. 79, no. 5, pp. 630-634. https://doi.org/10.1016/j.mehy.2012.07.039

APA

Morris, J. A., Harrison, L. M., Lauder, R. M., Telford, D. R., & Neary, R. (2012). Low dose, early mucosal exposure will minimize the risk of microbial disease. Medical Hypotheses, 79(5), 630-634. https://doi.org/10.1016/j.mehy.2012.07.039

Vancouver

Morris JA, Harrison LM, Lauder RM, Telford DR, Neary R. Low dose, early mucosal exposure will minimize the risk of microbial disease. Medical Hypotheses. 2012 Nov;79(5):630-634. doi: 10.1016/j.mehy.2012.07.039

Author

Morris, James A ; Harrison, Linda M ; Lauder, Robert M et al. / Low dose, early mucosal exposure will minimize the risk of microbial disease. In: Medical Hypotheses. 2012 ; Vol. 79, No. 5. pp. 630-634.

Bibtex

@article{862931025c2e4476a2c3df261e93e8ac,
title = "Low dose, early mucosal exposure will minimize the risk of microbial disease",
abstract = "In the 21st century we will rediscover the germ theory of disease: germs not only cause infection as described in standard textbooks but also have a pathogenic role in autoimmunity, atherosclerosis, cancer and even acute psychiatric conditions. In order to reduce morbidity and mortality caused by common organisms we should ensure that exposure is early, often, by the mucosal route and in low dose. Micro-organisms should be delivered daily throughout life by respiratory mucosal spray or enteric coated pill, in precise dose and in a predetermined schedule.",
author = "Morris, {James A} and Harrison, {Linda M} and Lauder, {Robert M} and Telford, {David R} and Richard Neary",
note = "Copyright {\textcopyright} 2012 Elsevier Ltd. All rights reserved.",
year = "2012",
month = nov,
doi = "10.1016/j.mehy.2012.07.039",
language = "English",
volume = "79",
pages = "630--634",
journal = "Medical Hypotheses",
publisher = "Churchill Livingstone",
number = "5",

}

RIS

TY - JOUR

T1 - Low dose, early mucosal exposure will minimize the risk of microbial disease

AU - Morris, James A

AU - Harrison, Linda M

AU - Lauder, Robert M

AU - Telford, David R

AU - Neary, Richard

N1 - Copyright © 2012 Elsevier Ltd. All rights reserved.

PY - 2012/11

Y1 - 2012/11

N2 - In the 21st century we will rediscover the germ theory of disease: germs not only cause infection as described in standard textbooks but also have a pathogenic role in autoimmunity, atherosclerosis, cancer and even acute psychiatric conditions. In order to reduce morbidity and mortality caused by common organisms we should ensure that exposure is early, often, by the mucosal route and in low dose. Micro-organisms should be delivered daily throughout life by respiratory mucosal spray or enteric coated pill, in precise dose and in a predetermined schedule.

AB - In the 21st century we will rediscover the germ theory of disease: germs not only cause infection as described in standard textbooks but also have a pathogenic role in autoimmunity, atherosclerosis, cancer and even acute psychiatric conditions. In order to reduce morbidity and mortality caused by common organisms we should ensure that exposure is early, often, by the mucosal route and in low dose. Micro-organisms should be delivered daily throughout life by respiratory mucosal spray or enteric coated pill, in precise dose and in a predetermined schedule.

U2 - 10.1016/j.mehy.2012.07.039

DO - 10.1016/j.mehy.2012.07.039

M3 - Journal article

C2 - 22959998

VL - 79

SP - 630

EP - 634

JO - Medical Hypotheses

JF - Medical Hypotheses

IS - 5

ER -